These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence. Dulin BR, Krum H. Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210 [Abstract] [Full Text] [Related]
26. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study. Krum H, Shi H, Pitt B, McMurray J, Swedberg K, van Veldhuisen DJ, Vincent J, Pocock S, Zannad F, EMPHASIS-HF Study Group. Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945 [Abstract] [Full Text] [Related]
27. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project. Schmedtje JF, Evans GW, Byerly W, King M, Goonan K, Blastock-Glenn C, Croft JB, Goff DC. N C Med J; 2003 Jul; 64(1):4-10. PubMed ID: 12774552 [Abstract] [Full Text] [Related]
30. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators. Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351 [Abstract] [Full Text] [Related]
34. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Lee DS, Mamdani MM, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV. Am J Med; 2004 May 01; 116(9):581-9. PubMed ID: 15093753 [Abstract] [Full Text] [Related]
35. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Levy PD, Nandyal D, Welch RD, Sun JL, Pieper K, Ghali JK, Fonarow GC, Gheorghiade M, O'Connor CM. Am Heart J; 2010 Feb 01; 159(2):222-230.e2. PubMed ID: 20152220 [Abstract] [Full Text] [Related]
37. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Dhaliwal AS, Habib G, Deswal A, Verduzco M, Souchek J, Ramasubbu K, Aguilar D, Ma TS, Jneid HM, Bolos M, Bozkurt B. Am J Cardiol; 2009 Jul 15; 104(2):270-5. PubMed ID: 19576359 [Abstract] [Full Text] [Related]
38. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Willenheimer R, van Veldhuisen DJ, Silke B, Erdmann E, Follath F, Krum H, Ponikowski P, Skene A, van de Ven L, Verkenne P, Lechat P, CIBIS III Investigators. Circulation; 2005 Oct 18; 112(16):2426-35. PubMed ID: 16143696 [Abstract] [Full Text] [Related]